samedan logo

 
 
spacer
home > pmps > summer 2002 > unit-dose nasal sprays - systemic delivery through the nose
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Unit-Dose Nasal Sprays - Systemic Delivery Through the Nose

In recent years, the nasal route has received a great deal of attention as a convenient and reliable method for the systemic administration of several compounds. In such cases, the nasal mucosa is used as a portal of entry for drugs into the bloodstream. Conventional drug delivery devices used for the nasal route include metering spray pumps, pressurised metered dose inhalers, squeeze bottles and, to a lesser extent, nasal drops. They are all used in conjunction with liquid formulations (solutions or suspensions). Another unusual but promising approach is to dispense dry powder formulations to/through the nasal mucosa.

Unit-Dose Nasal Sprays

These designate small disposable devices that deliver a limited number of sprays, for example, one or two shots (one per nostril). Another attribute is that they are 'ready to use' - there is no need to shake and/or prime the device prior to use. In addition, they can be used in any position. Examples of commercial pharmaceutical products that use unit-dose nasal spray devices:
Calcitonin, Aventis
Calcitonin, ICN
Inflexal Flu Vaccine, Berna Biotech
Sumatriptan, GlaxoSmithKline


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.


spacer
By Pierre Carlotti, Marketing Director at Valois' Pharmaceutical Division Pierre Carlotti is the Marketing Director at Valois' pharmaceutical division. From 1996, Pierre Carlotti held the position of Associate Director of Business Development. He has a bachelor and a masters degree in Biology and he also obtained a business degree from the Institut Supérieur du Commerce Extérieur (ISCE) in Paris.
Before working for Valois, Pierre occupied various commercial and marketing positions at Synthelabo and West Pharmaceutical Services.

spacer
Pierre Carlotti
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Novasep to sell its chromatography equipment division to Sartorius

Novasep, a leading supplier of services and technologies for the life sciences industry, and Sartorius Stedim Biotech, a subgroup of the life science company Sartorius, have signed an agreement regarding the proposed sale of Novasep’s chromatography equipment division.
More info >>

White Papers

Analysis of Biopharmaceuticals to Conform to ICHQ6B

RSSL

Worldwide, the pharmaceuticals market is anticipated to grow from more than USD 782 billion in 2011 to approach a value of just over USD 971 billion by the end of 2016, registering a CAGR of over 24%. In 2010 the average medicines expenditure per person within the UK was £271, and this is expected to increase with the ageing population. A significant and increasing proportion of these sales are protein-based biotherapeutics or biomolecules. Currently, these account for 19% of the total market, and are growing at twice the rate of traditional small molecule pharmaceuticals. It is predicted that close to 50% of the top 100 pharmaceutical products will be biomolecules by 2016. By far the largest segment of the biopharmaceutical market is the monoclonal antibody (MAb) with an estimated share of 25.6%, which corresponds to USD 51.1 billion.
More info >>

 
Industry Events

A Magic Triangle: Practical insights into lactose-based DPI formulations

30 June 2021, Online webinar

Three leading companies with complementary areas of expertise have joined forces to conduct a unique multidisciplinary study into lactose-based DPI formulations including magnesium stearate. Their findings will give generic players a head start in the development process so that they can tap into this rapidly growing market. Lactose specialist DFE Pharma, powder processing technology manufacturer Hosokawa Micron and machine-building expert Harro Hoefliger will be presenting the key insights from their research to interested parties during a joint webinar on the 30th of June.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement